MicroRNAs in adipose tissue fibrosis: Mechanisms and therapeutic potential

Adipose tissue fibrosis, characterized by abnormal extracellular matrix deposition within adipose tissue, signifies a crucial indicator of adipose tissue malfunction, potentially leading to organ tissue dysfunction. Various factors, including a high-fat diet, non-alcoholic fatty liver disease, and i...

Full description

Saved in:
Bibliographic Details
Main Authors: Mei Tian, Yang Zhou, Yitong Guo, Qing Xia, Zehua Wang, Xinying Zheng, Jinze Shen, Junping Guo, Shiwei Duan, Lijun Wang
Format: Article
Language:English
Published: KeAi Communications Co., Ltd. 2025-07-01
Series:Genes and Diseases
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2352304224000849
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850203728279240704
author Mei Tian
Yang Zhou
Yitong Guo
Qing Xia
Zehua Wang
Xinying Zheng
Jinze Shen
Junping Guo
Shiwei Duan
Lijun Wang
author_facet Mei Tian
Yang Zhou
Yitong Guo
Qing Xia
Zehua Wang
Xinying Zheng
Jinze Shen
Junping Guo
Shiwei Duan
Lijun Wang
author_sort Mei Tian
collection DOAJ
description Adipose tissue fibrosis, characterized by abnormal extracellular matrix deposition within adipose tissue, signifies a crucial indicator of adipose tissue malfunction, potentially leading to organ tissue dysfunction. Various factors, including a high-fat diet, non-alcoholic fatty liver disease, and insulin resistance, coincide with adipose tissue fibrosis. MicroRNAs (miRNAs) represent a class of small non-coding RNAs with significant influence on tissue fibrosis through diverse signaling pathways. For instance, in response to a high-fat diet, miRNAs can modulate signaling pathways such as TGF-β/Smad, PI3K/AKT, and PPAR-γ to impact adipose tissue fibrosis. Furthermore, miRNAs play roles in inhibiting fibrosis in different contexts: suppressing corneal fibrosis via the TGF-β/Smad pathway, mitigating cardiac fibrosis through the VEGF signaling pathway, reducing wound fibrosis via regulation of the MAPK signaling pathway, and diminishing fibrosis post-fat transplantation via involvement in the PDGFR-β signaling pathway. Notably, the secretome released by miRNA-transfected adipose-derived stem cells facilitates targeted delivery of miRNAs to evade host immune rejection, enhancing their anti-fibrotic efficacy. Hence, this study endeavors to elucidate the role and mechanism of miRNAs in adipose tissue fibrosis and explore the mechanisms and advantages of the secretome released by miRNA-transfected adipose-derived stem cells in combating fibrotic diseases.
format Article
id doaj-art-5896c7ae5e5c4d25aa5d7f2ae02d27f2
institution OA Journals
issn 2352-3042
language English
publishDate 2025-07-01
publisher KeAi Communications Co., Ltd.
record_format Article
series Genes and Diseases
spelling doaj-art-5896c7ae5e5c4d25aa5d7f2ae02d27f22025-08-20T02:11:26ZengKeAi Communications Co., Ltd.Genes and Diseases2352-30422025-07-0112410128710.1016/j.gendis.2024.101287MicroRNAs in adipose tissue fibrosis: Mechanisms and therapeutic potentialMei Tian0Yang Zhou1Yitong Guo2Qing Xia3Zehua Wang4Xinying Zheng5Jinze Shen6Junping Guo7Shiwei Duan8Lijun Wang9College of Pharmacy, Zhejiang University of Technology, Hangzhou, Zhejiang 310014, China; Geriatric Medicine Center, Department of Endocrinology, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang 310014, China; Key Laboratory of Novel Targets and Drug Study for Neural Repair of Zhejiang Province, School of Medicine, Hangzhou City University, Hangzhou, Zhejiang 310015, ChinaKey Laboratory of Novel Targets and Drug Study for Neural Repair of Zhejiang Province, School of Medicine, Hangzhou City University, Hangzhou, Zhejiang 310015, ChinaKey Laboratory of Novel Targets and Drug Study for Neural Repair of Zhejiang Province, School of Medicine, Hangzhou City University, Hangzhou, Zhejiang 310015, ChinaCollege of Pharmacy, Zhejiang University of Technology, Hangzhou, Zhejiang 310014, China; Key Laboratory of Novel Targets and Drug Study for Neural Repair of Zhejiang Province, School of Medicine, Hangzhou City University, Hangzhou, Zhejiang 310015, ChinaKey Laboratory of Novel Targets and Drug Study for Neural Repair of Zhejiang Province, School of Medicine, Hangzhou City University, Hangzhou, Zhejiang 310015, ChinaCollege of Pharmacy, Zhejiang University of Technology, Hangzhou, Zhejiang 310014, China; Key Laboratory of Novel Targets and Drug Study for Neural Repair of Zhejiang Province, School of Medicine, Hangzhou City University, Hangzhou, Zhejiang 310015, ChinaKey Laboratory of Novel Targets and Drug Study for Neural Repair of Zhejiang Province, School of Medicine, Hangzhou City University, Hangzhou, Zhejiang 310015, ChinaRainbowfish Rehabilitation and Nursing School, Hangzhou Vocational & Technical College, Hangzhou, Zhejiang 310018, China; Department of Clinical Medicine, School of Medicine, Hangzhou City University, Hangzhou, Zhejiang 310015, ChinaKey Laboratory of Novel Targets and Drug Study for Neural Repair of Zhejiang Province, School of Medicine, Hangzhou City University, Hangzhou, Zhejiang 310015, China; Corresponding author.Geriatric Medicine Center, Department of Endocrinology, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang 310014, China; Corresponding author.Adipose tissue fibrosis, characterized by abnormal extracellular matrix deposition within adipose tissue, signifies a crucial indicator of adipose tissue malfunction, potentially leading to organ tissue dysfunction. Various factors, including a high-fat diet, non-alcoholic fatty liver disease, and insulin resistance, coincide with adipose tissue fibrosis. MicroRNAs (miRNAs) represent a class of small non-coding RNAs with significant influence on tissue fibrosis through diverse signaling pathways. For instance, in response to a high-fat diet, miRNAs can modulate signaling pathways such as TGF-β/Smad, PI3K/AKT, and PPAR-γ to impact adipose tissue fibrosis. Furthermore, miRNAs play roles in inhibiting fibrosis in different contexts: suppressing corneal fibrosis via the TGF-β/Smad pathway, mitigating cardiac fibrosis through the VEGF signaling pathway, reducing wound fibrosis via regulation of the MAPK signaling pathway, and diminishing fibrosis post-fat transplantation via involvement in the PDGFR-β signaling pathway. Notably, the secretome released by miRNA-transfected adipose-derived stem cells facilitates targeted delivery of miRNAs to evade host immune rejection, enhancing their anti-fibrotic efficacy. Hence, this study endeavors to elucidate the role and mechanism of miRNAs in adipose tissue fibrosis and explore the mechanisms and advantages of the secretome released by miRNA-transfected adipose-derived stem cells in combating fibrotic diseases.http://www.sciencedirect.com/science/article/pii/S2352304224000849Adipose tissue fibrosisAdipose-derived stem cellExtracellular matrixmiRNAsSignaling pathways
spellingShingle Mei Tian
Yang Zhou
Yitong Guo
Qing Xia
Zehua Wang
Xinying Zheng
Jinze Shen
Junping Guo
Shiwei Duan
Lijun Wang
MicroRNAs in adipose tissue fibrosis: Mechanisms and therapeutic potential
Genes and Diseases
Adipose tissue fibrosis
Adipose-derived stem cell
Extracellular matrix
miRNAs
Signaling pathways
title MicroRNAs in adipose tissue fibrosis: Mechanisms and therapeutic potential
title_full MicroRNAs in adipose tissue fibrosis: Mechanisms and therapeutic potential
title_fullStr MicroRNAs in adipose tissue fibrosis: Mechanisms and therapeutic potential
title_full_unstemmed MicroRNAs in adipose tissue fibrosis: Mechanisms and therapeutic potential
title_short MicroRNAs in adipose tissue fibrosis: Mechanisms and therapeutic potential
title_sort micrornas in adipose tissue fibrosis mechanisms and therapeutic potential
topic Adipose tissue fibrosis
Adipose-derived stem cell
Extracellular matrix
miRNAs
Signaling pathways
url http://www.sciencedirect.com/science/article/pii/S2352304224000849
work_keys_str_mv AT meitian micrornasinadiposetissuefibrosismechanismsandtherapeuticpotential
AT yangzhou micrornasinadiposetissuefibrosismechanismsandtherapeuticpotential
AT yitongguo micrornasinadiposetissuefibrosismechanismsandtherapeuticpotential
AT qingxia micrornasinadiposetissuefibrosismechanismsandtherapeuticpotential
AT zehuawang micrornasinadiposetissuefibrosismechanismsandtherapeuticpotential
AT xinyingzheng micrornasinadiposetissuefibrosismechanismsandtherapeuticpotential
AT jinzeshen micrornasinadiposetissuefibrosismechanismsandtherapeuticpotential
AT junpingguo micrornasinadiposetissuefibrosismechanismsandtherapeuticpotential
AT shiweiduan micrornasinadiposetissuefibrosismechanismsandtherapeuticpotential
AT lijunwang micrornasinadiposetissuefibrosismechanismsandtherapeuticpotential